ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 114 filers reported holding ANAPTYSBIO INC in Q1 2023. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17 | +13.3% | 664 | 0.0% | 0.00% | – |
| Q1 2024 | $15 | -72.2% | 664 | -73.7% | 0.00% | – |
| Q4 2023 | $54 | +10.2% | 2,528 | -7.2% | 0.00% | – |
| Q3 2023 | $49 | -10.9% | 2,725 | 0.0% | 0.00% | – |
| Q2 2023 | $55 | +25.0% | 2,725 | +33.3% | 0.00% | – |
| Q1 2023 | $44 | -43.6% | 2,045 | -18.7% | 0.00% | -100.0% |
| Q4 2022 | $78 | -99.9% | 2,515 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $64,000 | +25.5% | 2,515 | 0.0% | 0.00% | – |
| Q2 2022 | $51,000 | -10.5% | 2,515 | +8.4% | 0.00% | – |
| Q1 2022 | $57,000 | -76.5% | 2,321 | -46.1% | 0.00% | -100.0% |
| Q2 2019 | $243,000 | +7.0% | 4,303 | +38.3% | 0.01% | 0.0% |
| Q1 2019 | $227,000 | +12.9% | 3,111 | +10.2% | 0.01% | +20.0% |
| Q2 2018 | $201,000 | -19.3% | 2,824 | +18.2% | 0.01% | -28.6% |
| Q1 2018 | $249,000 | +2.0% | 2,390 | -1.4% | 0.01% | 0.0% |
| Q4 2017 | $244,000 | – | 2,425 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $91,347,000 | 18.37% |
| EcoR1 Capital, LLC | 7,521,024 | $261,356,000 | 8.33% |
| GREAT POINT PARTNERS LLC | 592,250 | $20,581,000 | 4.57% |
| FRAZIER MANAGEMENT LLC | 899,700 | $31,265,000 | 2.41% |
| Boxer Capital, LLC | 1,300,000 | $45,175,000 | 1.76% |
| Palo Alto Investors LP | 436,592 | $15,172,000 | 0.97% |
| Rock Springs Capital Management LP | 538,700 | $18,720,000 | 0.43% |
| Eversept Partners, LP | 182,612 | $6,345,767 | 0.40% |
| EAM Global Investors LLC | 58,683 | $2,039,000 | 0.36% |
| Woodline Partners LP | 609,981 | $21,197,000 | 0.30% |